ARCKU
Arbor Rapha Capital Bioholdings Corp I
Chart
Stats
Earnings
News
Splits
Dividends
Earnings
Actual EPS |
---|
Consensus EPS |
Estimated EPS |
Number of Estimates |
EPS Surprise |
Stats
Summary
RCM is an investment management firm located in Miami, Florida focused on identifying and managing strategic investments in early stage, non-public biotechnology companies, with a strategy of identifying and growing revolutionary and disruptive ideas in medicine, healthcare, and biotechnology before others can see their value. RCM executes its investment strategy by making equity and convertible debt investments in privately held companies that RCM believes have developed a transformative product, technology, or process that will drive long-term value creation for shareholders. RCM’s portfolio companies currently focus on a wide range of targets, including immunotherapies, medical devices, ocular diseases, genome editing, cell and gene therapy and bioprinting.
Market Cap: 205 Million
Primary Exchange: NASDAQ
Website: arcbiocorp.com
Shares Outstanding: 15 Million
Float: 0
Dividend: 0.0 (0.0%)
Beta: 0.0
Sector:
Industry:
Ethical Flags
Longest drawdown: 278 trading days
From: 2022-02-23 To: 2022-12-01
Lowest Point:
Ex-Date | Payment Date | Record Date | Declared Date | Amount | Flag | Dividend Type | Qualified | Indicated |
---|
Ex-Date | Declared Date | Record Date | Payment Date | Ratio | To Factor | For Factor |
---|